BlackRock
PJP icon

BlackRock’s Invesco Pharmaceuticals ETF PJP Stock Holding History

BlackRock’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.9K Sell
230
-3,470
-94% -$367K ﹤0.01% 5275
2025
Q4 		$387K Buy
+3,700
New +$372K ﹤0.01% 4551
2016
Q1 		– Sell
-50
Closed -$3K – 3729
2015
Q4 		$3K Buy
+50
New +$3.54K ﹤0.01% 3264

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock's PJP Position: Q1 2026 in Review

BlackRock reduced its Invesco Pharmaceuticals ETF (PJP) stake by 94% in Q1 2026, selling an estimated $367K and leaving 230 shares worth $23.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5275.

BlackRock first reported a position in PJP in Q4 2015 and has held it in 3 quarters since. The position peaked at $387K in Q4 2025. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

  • BlackRock held 230 shares of Invesco Pharmaceuticals ETF worth $23.9K as of Q1 2026.
  • BlackRock sold 3,470 Invesco Pharmaceuticals ETF shares in Q1 2026, an estimated $367K.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #5275 holding.
  • BlackRock first reported a position in Invesco Pharmaceuticals ETF in Q4 2015 and has held it in 3 quarters since.
  • BlackRock's Invesco Pharmaceuticals ETF position peaked at $387K in Q4 2025.
  • 119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.